Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedJan 26, 2022
DataAggregated Company Financials
Companies172
  • 7D-1.5%
  • 3M6.2%
  • 1Y25.4%
  • YTD-4.0%

Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by a pullback from Oneness Biotech of 6.7%. Meanwhile, PharmaEssentia actually outperformed within the industry, gaining 15% in the last week. This takes the industry's 12 month performance to a gain of 25%.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 26 Jan 2022NT$1.1tNT$202.1bNT$14.1b21.5x
Fri, 24 Dec 2021NT$1.2tNT$202.1bNT$14.1b21.9x
Sun, 21 Nov 2021NT$1.1tNT$202.4bNT$13.3b20.4x
Tue, 19 Oct 2021NT$1.0tNT$197.1bNT$14.2b20.5x
Thu, 16 Sep 2021NT$1.0tNT$197.1bNT$14.2b21.5x
Sat, 14 Aug 2021NT$1.1tNT$197.0bNT$14.1b22x
Wed, 09 Jun 2021NT$1.1tNT$191.4bNT$14.8b20.9x
Tue, 02 Mar 2021NT$940.9bNT$186.1bNT$9.7b19.1x
Fri, 04 Dec 2020NT$923.3bNT$179.1bNT$4.8b20.9x
Mon, 07 Sep 2020NT$955.7bNT$174.2bNT$2.1b22.7x
Sun, 31 May 2020NT$789.5bNT$171.3b-NT$2,449,886,500.0023.4x
Wed, 04 Mar 2020NT$637.6bNT$170.7b-NT$2,703,537,000.0021x
Sat, 07 Dec 2019NT$664.2bNT$167.5bNT$1.6b19.6x
Tue, 10 Sep 2019NT$637.2bNT$169.8bNT$3.1b19.6x
Mon, 03 Jun 2019NT$638.8bNT$173.0bNT$3.9b20.8x
Thu, 07 Mar 2019NT$673.9bNT$174.5bNT$5.3b21.5x
PE Ratio

19.4x

Total Market Cap: NT$648.3bTotal Earnings: NT$5.3bTotal Revenue: NT$174.5b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 21.0x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 39% per year over the last three years, and revenues for these companies have grown 5.0% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

Biotech0.076%
Healthcare Services-1.58%
Healthtech-1.64%
Pharma-2.15%
Medical Equipment-2.99%
Life Sciences-3.80%

Industry PE: Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 23.5x. This is likely because analysts are expecting annual earnings growth of 218%, which is higher than its past year's earnings growth of 19% per year. Meanwhile, investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 20.1x.

Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 218% over the next 5 years. This is better than it's past earnings growth rate of 19% per year. Meanwhile, the Medical Equipment industry is expected to see its earnings grow by 9.1% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$289.0016.5%
+NT$11.2b
216.9%PS138.8x
6586 CHO PharmaNT$123.0035.6%
+NT$5.9b
400.0%PB12.2x
4174 OBI PharmaNT$118.508.7%
+NT$1.9b
0.9%PS249x
6562 UBI PharmaNT$72.908.6%
+NT$611.0m
n/aPS14.1x
6696 Lin BioScienceNT$213.004.2%
+NT$586.4m
100.9%PB25.6x
Simply Wall St‚ĄĘ
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6589

NT$100.50

EirGenix

7D

-3.8%

1Y

152.8%

4142

NT$39.60

Adimmune

7D

-8.3%

1Y

-21.7%